COVID Connections

Find the latest treatments, research and discoveries on COVID-19.

Videos and Articles




American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases. v4

COVID-19 Outcomes in Patients Undergoi]ng B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review.

Baricitinib and dexamethasone for hospitalized patients with COVID-19.

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.

Interferon therapy for COVID-19 and emerging infections: Prospects and concerns.

Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?

Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, p3: The role of GM-CSF.

Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, p4: The role of JAK inhibition.

Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in immune mediated inflammatory disease patients undergoing B cell depleting therapy and those with inborn errors of humoral immunity. RMD Open 2022.

The evolving role of the rheumatology practitioner in the care of immunocompromised patients in the COVID-19 era. Arthritis and Rheumatology 2022.

Long COVID: defining the role of rheumatology in care and research.

Outpatient Management of COVID-19: A Primer for the Dermatologist.

Breakthrough SARS-CoV-2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis.

VIDEO: Rheumatic Diseases and COVID-19

VIDEO: COVID-19 autoimmunity, prevention and management

VIDEO: Managing COVID-19 in IMIDS Patients

VIDEO: COVID round up in other IMIDS – special considerations
Ead-messages-offsite-icon-1